2021: Nanoss launches strategic collaboration in the development of novel diagnostic implants for the treatment of congestive heart failure (CHF)

Nanoss has launched a strategic collaboration with international experts for the development of novel diagnostic implants and procedures for the treatment of heart failure patients.

In the course of the long-term joint development, which involves several interdisciplinary partners from industry, medicine and research, innovative technologies will be made available in the coming years that will combine home monitoring of the disease with new telemedical approaches and provide improved accompanying forms of therapy.

Dr. Alexander Kaya, CEO of NanoScale Systems, Nanoss GmbH said, “Congestive heart failure is the progressive weakening of the heart muscle that can occur due to a variety of causes, particularly heart attack, hypertension and myocarditis.”

Heart failure is characterized by high mortality, frequent hospitalizations and a significant impairment of quality of life. Nine million deaths in Europe alone are attributed to this disease each year.

“The ability to monitor certain vital data, such as intracardiac pressure, daily at home and assess them telemetrically under a physician’s supervision could provide early warning, often many weeks before acute heart failure (decompensation) becomes apparent”, Kaya said.

Current gold standard methods for accurate and routine assessment of intracardiac pressure often require multiple or repetitive invasive or surgical procedures (e.g., cardiac catheterization) and are associated with health risks for the patient. They are therefore unsuitable for daily use.

“We launched this novel development to overcome the serious drawbacks of current invasive monitoring techniques in terms of patient safety. Our mobile sensing and communication platform is designed to be implanted long-term using minimally invasive techniques and provide continuous real-time monitoring of intracardiac pressure and other hemodynamic vital data over several years. Using new manufacturing methods of microsystems engineering, nanotechnology and medically proven materials, we can further increase the miniaturization of the sensors while meeting the high physiological requirements of the sensors, such as small size, biocompatibility, durability and patient safety” Kaya added.

Continuous monitoring of blood pressure inside the heart is crucial for early prediction of heart failure. Based on reliable physiological data combined with proactive patient management, the consequences of the disease, if detected early enough, can be reduced and the likelihood of hospitalization reduced, as shown by numerous clinical studies from Europe and North America.

The development project, which is scheduled to run over several years, is funded by the German Federal Ministry of Education and Research (BMBF).


16.03.2017: Hessian Minister for Federal and European Affairs Lucia Puttrich talks with Nanoss GmbH about Hessen as a research location


Lucia Puttrich, Hessian Minister for Federal and European Affairs

Minister of State Lucia Puttrich spoke with NanoScale Systems, Nanoss GmbH on Thursday about the European funding program Horizon 2020. Among other things, the conversation focused on new methods for improving the treatment options for heart failure.

“Hessian innovations not only benefit the region, but also Germany and Europe in the long term,” said Lucia Puttrich during her visit to Darmstadt. The great innovative potential of small and medium-sized companies shows their great importance for Hessen as a location for research and development, she added.

Nanoss GmbH is developing extremely miniaturized sensors that will be used for continuous blood pressure measurement in the body and that place particularly high demands on minimal invasiveness, biocompatibility and energy efficiency.

Dr. Alexander Kaya, Managing Director NanoScale Systems, Nanoss GmbH said, “Sensors that provide long-term monitoring of vital life functions in the body have now been among the greatest unsolved challenges in medical technology for more than two decades. Only by combining sophisticated technologies and bringing together multidisciplinary experts will true innovations be created that will provide patients with the best possible and most gentle therapy.

Read the full article here (in German)



2016: Renowned publisher nature brings pathbreaking results on novel nano3DSense-sensors in September issue of “nature communications” journal

Renowned scientific publisher nature has released in its September issue of “nature communications” journal groundbreaking results on sub-micrometre force sensors for high-speed nanocharacterization and biosensing using novel 3D nanoprinting. Thanks to nano3DSense nanoprinting technology the smallest known and commercially available sensors for force and pressure measuring are provided that are now surpassing in terms of compactness, sensing speed and sensitivity.


Nature Communications is a peer-reviewed open access scientific journal published by the influential Nature Publishing Group. According to the “Journal Citation Reports (JCR)”, the journal has a 2015 impact factor of 11.329. In 2012 JCR placed Nature Communications at #3 and “Scientific Reports” at #8 in the top 10 Multidisciplinary Sciences titles.


Read article free of charge online on “Direct-write nanoscale printing of nanogranular tunnelling strain sensors for sub-micrometre cantilevers”

(Nature Communications 7, Article number: 12487 (2016))



2016: Nanoss wins German BMBF grant for novel sensors


Nanoss GmbH receives German BMBF funding (“Bundesministerium für Bildung und Forschung”) for its next generation gas sensors based on the novel nano3DSense 3D Nanoprinting Technology


2015: TechConnect Innovation Award goes to Nanoss GmbH for highly customizable sensors

TechConnect World Innovation Conference & Expo 2015, June 14-17, 2015, Washington, DC

Nanoss GmbH receives the renowned TechConnect Innovation Award 2015 for “Novel 3D-Printing on the Nanoscale for Tailored Sensors and Electronics”, Washington, DC

TechConnect 2015 IMG_0023



2015: Nanoss GmbH at TechConnect World Innovation Conference & Expo, Washington, DC, June 14-17



Nanoss GmbH at the TechConnect World Innovation Conference:

Talk at Biotech, Medical & Pharma Session: Innovation Spotlights: Medical Devices



2015: Nanoss GmbH at HANNOVER MESSE, Germany, April 13-17


Download our new company profile (both in English and German) “Neue Werkstoffe, Nanotechnologie – Made in Germany” at HANNOVER MESSE 2015, Germany in cooperation with VDI (Verein Deutscher Ingenieure) and BMBF (Bundesministerium für Bildung und Forschung)


Page 146



2014: Best Sensor Award 2014 for nano3DSense


Nanoss GmbH wins the ‘Best Sensor Award 2014’ of the renowned ‘Sensors’ magazine for ‘A Tunable Strain Sensor Using Nanogranular Metals’


2013: Nanoss GmbH starts the FP7 EU project FALCON for next generation sensors for highspeed atomic force microscopy (AFM)

Logo Seventh Framework Programme

Nanoss GmbH wins EU funding FALCON: Nanoss follows up on the successful EU project ALBICAN and starts the FP7 successor project FALCON for the market introduction phase of the next generation of self-sensing highspeed AFM cantilevers.

Visit project web site:

Logo Falcon




2012: Nanoss at Sensor & Test Expo, Nürnberg, Germany, May 22-24


Nanoss at Sensor & Test 2012 in the ‘Sensors and Measuring System GMA/ITG Conference’ with the invited presentation ‘New pathways for pressure and force sensor systems – Strain sensing with nanogranular metals’.


2011: nano3DSense starts in the FP7 EU-Projekt ALBICAN for novel sensors

Logo Seventh Framework Programme

Nanoss GmbH wins EU funding ALBICAN: The nano3DSense sensor platform enters the field of atomic force microscopy (AFM): Nanoss has successfully started the EU funded FP7 project ALBICAN for the development of novel self-sensing cantilevers for the use in ultrafast atomic force microscopy as well as bio and life science applications.


Logo albicanDownload article: Introducing novel Atomic Force Microscopy (AFM) with 3D nanoprinting.


Visit project web site: